Results of seven-year clinical trial follow-up indicate superiority of Globus Medical’s SECURE-C® cervical disc vs. ACDF in the treatment of cervical disc disease.
curasan entered into an exclusive agreement with Implantcast for distribution of CERASORB bone regeneration products in Austria, Germany and Switzerland.
ORTHOWORLD estimates Medtronic’s FY2Q18 revenue at US $739.0MM, -0.4% vs. FY2Q17 (quarter ended 10/27/17). The company posted YTD revenue of $2,226.0MM, +1.2% vs. the prior year’s period.